NCT05469152

Brief Summary

The purpose of the study is to determine the accuracy of detachable string magnetically controlled capsule endoscopy(DS-MCE) as a follow-up method for patients with previous esophageal diseases.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
310

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2019

Typical duration for not_applicable

Geographic Reach
1 country

7 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2019

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

July 11, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 21, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2022

Completed
Last Updated

July 21, 2022

Status Verified

July 1, 2022

Enrollment Period

3.2 years

First QC Date

July 11, 2022

Last Update Submit

July 19, 2022

Conditions

Keywords

esophageal diseasescapsule endoscopy

Outcome Measures

Primary Outcomes (1)

  • The diagnostic accuracy of the ds-MCE in identifying esophageal diseases in comparison to standardized EGD

    To assess the diagnostic accuracy of the ds-MCE as a follow-up method for patients with previous esophageal diseases, using EGD as the gold standard.

    2 weeks

Secondary Outcomes (4)

  • Number of quadrants visualized at Z-line by ds-MCE

    2 weeks

  • Scores of cleanliness of Z-line area

    2 weeks

  • Number of ds-MCE associated adverse events

    2 weeks

  • The patient satisfaction of the ds-MCE through questionnaires

    2 weeks

Study Arms (1)

ds-MCE and EGD

EXPERIMENTAL

All the enrolled participants will undergo the examination of detachable string magnetically controlled capsule endoscopy (ds-MCE) first, followed by EGD within 48 hours.

Diagnostic Test: ds-MCE and EGD

Interventions

ds-MCE and EGDDIAGNOSTIC_TEST

Procedure of ds-MCE: The ds-MCE system mainly consists of two parts: the NaviCam magnetic capsule endoscopy guidance system and the detachable string part. The capsule, which is partially enclosed within the sleeve, can be actively moved in the esophagus through the control of string. Investigator can examine the entire esophagus several times under real time views. The capsule then could be detached from the string system through injecting air into the hollow string with the syringe after completing the examination of esophagus. Then, the examination of stomach under magnetic control and small bowel under the natural action of peristalsis follows. Procedure of EGD: The EGD will be performed using conventional upper gastrointestinal video endoscopy, according to the standard procedure at individual centers. EGD will be performed within 48 hours after ds-MCE procedure and usually during the same endoscopic session.

ds-MCE and EGD

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Gender is not limited.
  • Patients aged between 18-75 years or older.
  • Both inpatients and outpatients.
  • Patients with previous esophageal diseases who are scheduled to undergo EGD for follow-up.
  • Able to provide informed consent.

You may not qualify if:

  • Patients aged less than 18 years.
  • Patients with active upper gastrointestinal bleeding.
  • Patients who have participated in or are participating in other clinical trials within three months.
  • Patients with cancer on active treatment with chemotherapy and/or radiation therapy.
  • Pregnancy or suspected pregnancy.
  • Suspected or known intestinal stenosis or other known risk factors for capsule retention.
  • Pacemaker or other implanted electromedical devices which could interfere with magnetic resonance.
  • Patients with dysphagia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Ruijin Hospital

Shanghai, China

RECRUITING

Shanghai Changhai Hospital

Shanghai, China

RECRUITING

Shanghai General Hospital

Shanghai, China

RECRUITING

Shanghai Sixth People's Hospital

Shanghai, China

RECRUITING

Xuhui District Central Hospital

Shanghai, China

RECRUITING

Yangpu District Central Hospital

Shanghai, China

RECRUITING

Zhongshan Hospital

Shanghai, China

RECRUITING

Related Publications (8)

  • Chen YZ, Pan J, Luo YY, Jiang X, Zou WB, Qian YY, Zhou W, Liu X, Li ZS, Liao Z. Detachable string magnetically controlled capsule endoscopy for complete viewing of the esophagus and stomach. Endoscopy. 2019 Apr;51(4):360-364. doi: 10.1055/a-0856-6845. Epub 2019 Mar 1.

    PMID: 30822803BACKGROUND
  • de Franchis R, Eisen GM, Laine L, Fernandez-Urien I, Herrerias JM, Brown RD, Fisher L, Vargas HE, Vargo J, Thompson J, Eliakim R. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology. 2008 May;47(5):1595-603. doi: 10.1002/hep.22227.

    PMID: 18435461BACKGROUND
  • Chen WS, Zhu LH, Li DZ, Chen L, Wu YL, Wang W. String esophageal capsule endoscopy with real-time viewing improves visualization of the distal esophageal Z-line: a prospective, comparative study. Eur J Gastroenterol Hepatol. 2014 Mar;26(3):309-12. doi: 10.1097/MEG.0000000000000038.

    PMID: 24429971BACKGROUND
  • de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000 Nov;33(5):846-52. doi: 10.1016/s0168-8278(00)80320-7. No abstract available.

    PMID: 11097497BACKGROUND
  • Zou WB, Hou XH, Xin L, Liu J, Bo LM, Yu GY, Liao Z, Li ZS. Magnetic-controlled capsule endoscopy vs. gastroscopy for gastric diseases: a two-center self-controlled comparative trial. Endoscopy. 2015 Jun;47(6):525-8. doi: 10.1055/s-0034-1391123. Epub 2015 Jan 15.

    PMID: 25590177BACKGROUND
  • Liao Z, Hou X, Lin-Hu EQ, Sheng JQ, Ge ZZ, Jiang B, Hou XH, Liu JY, Li Z, Huang QY, Zhao XJ, Li N, Gao YJ, Zhang Y, Zhou JQ, Wang XY, Liu J, Xie XP, Yang CM, Liu HL, Sun XT, Zou WB, Li ZS. Accuracy of Magnetically Controlled Capsule Endoscopy, Compared With Conventional Gastroscopy, in Detection of Gastric Diseases. Clin Gastroenterol Hepatol. 2016 Sep;14(9):1266-1273.e1. doi: 10.1016/j.cgh.2016.05.013. Epub 2016 May 20.

    PMID: 27211503BACKGROUND
  • Liao Z, Gao R, Xu C, Xu DF, Li ZS. Sleeve string capsule endoscopy for real-time viewing of the esophagus: a pilot study (with video). Gastrointest Endosc. 2009 Aug;70(2):201-9. doi: 10.1016/j.gie.2008.10.043. Epub 2009 Mar 14.

    PMID: 19286182BACKGROUND
  • Hosoe N, Naganuma M, Ogata H. Current status of capsule endoscopy through a whole digestive tract. Dig Endosc. 2015 Jan;27(2):205-15. doi: 10.1111/den.12380. Epub 2014 Oct 20.

    PMID: 25208463BACKGROUND

MeSH Terms

Conditions

Esophageal Diseases

Interventions

Endoscopy, Digestive System

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Zhuan Liao

    Changhai Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 11, 2022

First Posted

July 21, 2022

Study Start

July 15, 2019

Primary Completion

September 15, 2022

Study Completion

September 15, 2022

Last Updated

July 21, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will share

After finishing this study, we will make the data available to other researchers: including study protocol, statistical analysis plan (SAP), informed consent form (ICF), clinical study report (CSR)

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
3 years.
Access Criteria
The website of the journal where the results published, and ClinicalTrials.gov web site.

Locations